Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
65.50    1.00 (1.55%)
Bid:
65.00
Ask:
65.90
Spread: 0.90 (1.385%)
Market Cap: £578.65m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Director/PDMR Shareholding

10 May 2018 18:18

RNS Number : 7330N
IP Group PLC
10 May 2018
 

FOR RELEASE ON

10 May 2018

 

IP Group plc - LTIP

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), the developer of intellectual property-based businesses, announces that it has made conditional awards of 5,025,302 ordinary shares of two pence each ("Shares") to its executive directors, other persons discharging managerial responsibilities ("PDMRs") and certain other employees under its Long Term Incentive Plan (the "LTIP").

 

The performance measures attaching to the 2018 awards are based on the achievement of targets linked to growth in the Company's "hard" net assets ("Hard NAV") and total shareholder return ("TSR") as described in the Directors' Remuneration Report of the Annual Report and Accounts. The starting point for the TSR target is 134.5p, being the one-month average closing price up to the date of grant. The starting point for the Hard NAV performance measure is the Group's audited Hard NAV at 31 December 2017 of £1,326.2m. The number of Shares conditionally awarded was calculated using the closing price on 9 May 2018 of 139.2p.

 

Assuming satisfaction of the conditions in full, the awards will ordinarily vest on or after 31 March 2021 and the Shares will be issued as soon as practicable after these dates. Any such Shares would be subject to a minimum two-year post-vesting holding period.

 

Conditional awards over 2,539,512 Shares have been made to the executive directors and other PDMRs, as set out in the table below, with awards over a further 2,485,790 to other of the Group's employees.

 

Executive Director/PDMR

Maximum number of Sharesconditionally awarded in respectof 2018 LTIP

Maximum number of conditionally awarded Shares outstanding at the date of this announcement

Alan Aubrey

894,397

2,415,852

David Baynes

395,115

1,547,028

Mike Townend

395,115

1,101,028

Greg Smith

395,115

1,080,489

Sam Williams

395,115

725,170

Mark Reilly

64,655

163,736

 

The number of Shares stated is the maximum number that could be issued to each executive director or PDMR upon full satisfaction of the performance conditions attaching to the awards.

As at the date of this announcement, a total of 12,651,184 Shares conditionally awarded to executive directors, other PDMRs and employees of IP Group remain outstanding under the IP Group LTIP and subject to performance conditions.

 

The Company currently has 1,059,144,595 Ordinary Shares in issue.

 

The following information is being disclosed pursuant to the requirements of MAR.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Alan AubreyMike TownendGreg SmithDavid BaynesSam WilliamsMark Reilly

2

Reason for the notification

a)

Position/status

Director Chief Executive OfficerDirector Chief Investment OfficerDirector Chief Financial OfficerDirector Chief Operating OfficerPDMR Managing Partner, Life SciencesPDMR Managing Partner, Technology

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

 ISIN: GB00B128J450

b)

Nature of the transaction

Grant of Options under the IP Group plc LTIP

c)

Currency

GBP

d)

Price(s) and volume(s)

Name(s)

Price(s)

Volume(s)

Alan Aubrey

Nil

894,397

Mike Townend

Nil

395,115

Greg Smith

Nil

395,115

David Baynes

Nil

395,115

Sam Williams

Nil

395,115

Mark Reilly

Nil

64,655

 

e)

Aggregated information

-Aggregated volume

- Price

- Aggregated total

 

Aggregated Number of Shares Granted Under the LTIP to Directors and PDMRs on 9 May 2018: 2,539,512

Price: £ nil

f)

Date of the transaction

9 May 2018.

g)

Place of the transaction

London Stock Exchange, Main Market

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Alan Aubrey, Chief Executive OfficerGreg Smith, Chief Financial OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

 

Andrew Wilson

+44 (0) 7810 636995

Martha Walsh

+44 (0) 7876 245962

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO. For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGGUQGAUPRGMU
Date   Source Headline
30th Oct 20196:16 pmRNSHolding(s) in Company
28th Oct 20196:06 pmRNSHolding(s) in Company
9th Oct 201910:22 amRNSHolding(s) in Company
8th Oct 20196:08 pmRNSSAYE scheme
2nd Oct 20195:24 pmRNSHolding(s) in Company
2nd Oct 20195:18 pmRNSHolding(s) in Company
27th Sep 20195:58 pmRNSHolding(s) in Company
26th Sep 20195:44 pmRNSHolding(s) in Company
26th Sep 20195:12 pmRNSHolding(s) in Company
10th Sep 20197:00 amRNSHalf-yearly results
2nd Sep 201911:48 amRNSHolding(s) in Company
19th Aug 20192:25 pmRNSHolding(s) in Company
13th Aug 20193:31 pmRNSHolding(s) in Company
1st Aug 20194:19 pmRNSHolding(s) in Company
15th Jul 20197:09 amRNSCeres Power signs collaboration with Doosan
15th Jul 20197:00 amRNSIstesso announces positive P2a study of MBS2320
9th Jul 20191:35 pmRNSHolding(s) in Company
9th Jul 201910:50 amRNSHolding(s) in Company
13th Jun 20197:00 amRNSAppointment of Non-executive Director
7th Jun 20195:12 pmRNSHolding(s) in Company
7th Jun 20191:19 pmRNSHolding(s) in Company
31st May 20197:00 amRNSHolding(s) in Company
28th May 20196:04 pmRNSHolding(s) in Company
28th May 20195:42 pmRNSResult of AGM
28th May 201911:13 amRNSAppointment of Caroline Brown as NED
16th May 20196:21 pmRNSWithdrawal of resolution from 2019 AGM
3rd May 20199:38 amRNSAppointment of corporate broker
26th Apr 20196:23 pmRNSLTIP & DBSP awards; DBSP option exercise
18th Apr 20192:54 pmRNSAnnual Financial Report
15th Apr 201911:55 amRNSHolding(s) in Company
11th Apr 20197:12 amRNSDiurnal positive advice from EMA for Chronocort
26th Mar 20197:00 amRNSFinal Results
19th Mar 20193:32 pmRNSHolding(s) in Company
8th Mar 20192:20 pmRNSHolding(s) in Company
5th Mar 20195:54 pmRNSHolding(s) in Company
12th Feb 20199:36 amRNSDirector Declaration
12th Feb 20199:03 amRNSFLF aims for fusion by mid 2019 on Machine 3
28th Jan 20197:00 amRNSPortfolio co Featurespace completes £25m round
18th Jan 20191:25 pmRNSHolding(s) in Company
3rd Jan 20198:56 amRNSHolding(s) in Company
11th Dec 20187:00 amRNSWaveOptics completes £20.0m funding round
10th Dec 20187:05 amRNSAvacta signs deal with LG Chem worth up to $310m
4th Dec 20185:49 pmRNSPortfolio co Ceres finalises deal with Weichai
3rd Dec 20187:00 amRNSUltrahaptics completes £35.0m funding round
31st Oct 20185:52 pmRNSDirector Declaration
18th Oct 20182:00 pmRNSAmgen invests £50m in Oxford Nanopore Technologies
15th Oct 20187:00 amRNSPortfolio co Garrison completes £22.9m financing
8th Oct 20187:07 amRNSPortfolio co Diurnal headline data for Chronocort
19th Sep 20189:51 amRNSDirector/PDMR Shareholding
17th Sep 20184:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.